Group B Streptococcus Isolated from Bacteremic Patients: Serotypes and Antimicrobial Susceptibilities
Case report PDF Jeong Won Shin, M.D., Kyoung Ho Roh., M.D., Kyungwon Lee, M.D. and Yunsop Chong, Ph.D. Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea Corresponding to Kyungwon Lee Ann Clin Microbiol 1999;2(2):220-224.Copyright © Korean Society of Clinical Microbiology. Abstract Group B Streptococcus (GBS, S. agalactiae) is known to be the leading cause of neonatal sepsis and meningitis and the infection has been increasingly noted in adults, particularly in those with underlying diseases. Penicillin G is the drug of choice for GBS infection. However, the MIC of penicillin for GBS is greater than that for S. pyogenes. Therefore some GBS infections may be difficult to be treated. However, in Korea, our knowledge on GBS infection is limited. We observed 7 cases of GBS bacteremia during 1993-1996 in a hospital. Of the 7 patients, 3 were less than one month of age with no known